Treatment of relapsed acute promyelocytic leukemia by arsenic trioxide in Iran

Archives of Iranian Medicine

Volumn 14, Issue 3, 2011, Pages 167-169

  Alimoghaddam, Kamran ^a   Ghavamzadeh, Ardeshir ^a   Jahani, Mohamad ^a   Mousavi, Asadolah ^a   Iravani, Masoud ^a   Rostami, Shahrbano ^a   Ghaffari, Hamidolah ^a   Hosseini, Roholah ^b   Jalili, Mehdi ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute promyelocytic leukemia; Arsenic trioxide; Relapse

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; RETINOIC ACID; ORGANOARSENIC DERIVATIVE; OXIDE;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; COMPLETE REMISSION; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; IRAN; LEUKEMIA RELAPSE; MORPHOMETRICS; OVERALL SURVIVAL; PROMYELOCYTIC LEUKEMIA; SALVAGE THERAPY; TREATMENT RESPONSE; ADOLESCENT; AGED; CHILD; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MORTALITY; REMISSION; TREATMENT OUTCOME; TUMOR RECURRENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; ARSENICALS; CHILD; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IRAN; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OXIDES; REMISSION INDUCTION; SALVAGE THERAPY; TREATMENT OUTCOME; TRETINOIN; YOUNG ADULT;

EID: 79961197263     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, et al. Use of all-trans retinoic acid in the treatment of APL. Blood. 1988; 72: 567-572.
2. Chen ZX, Xue YQ, Zhang R, Tao RF, Xia XM, Li C, et al. A clinical and experimental study on all-trans retinoic acid treated acute promyelocytic leukemia patients. Blood. 1991; 78: 1413-1419.
3. Chomienne C, Ballerini P, Balitrand N, Daniel MT, Fenaux P, Castaigne S, et al. All-trans retinoic acid as a differentiation therapy foracute promyelocytic leukemia. I. Clinical results. Blood. 1990; 76: 1704-1709.
4. Zhang P, Wang S, Hu X. Arsenic trioxide treated 72 cases of acute promyelocytic leukemia. Chin J Hematol. 1996; 17: 58-62.
5. Shen Z, Chen G, Ni J. Use of arsenic trioxide in the treatment of APL, clinical efficacy and pharmacokinetics in relapsed patients. Blood. 1997; 89: 3354-3360.
6. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Eng J Med. 1998; 339: 1341-1348. (Pubitemid 28509343)
7. Niu C, Yan H, Yu T, Sun HP, Liu JX, Li XS, et al. Studies on treatment ofacute promyelocytic leukemia with arsenic trioxide: Remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood. 1999; 94: 3315-3324. (Pubitemid 29536124)
8. Ghavamzadeh A, Alimoghaddam K, Ghaffari SH, et al. Treatment of acute promyelocytic leukemia without ATRA and/or chemotherapy. Ann Oncol. 2006; 17: 131-134. (Pubitemid 43033852)
9. Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, et al. Management of acute promyelocytic leukemia: Recommendations from an expert panel on behalf of the European Leukemia Net. Blood. 2009; 113: 1875-1891.
10. Park J, Panageas K, Schymura M. A population-based study in acute promyelocytic leukemia (APL) suggests a higher early death rate and lower overall survival than commonly reported in clinical trials: Data from the Surveillance, Epidemiology, and End Results (SEER) Program and the New York State Cancer Registry in the United States between 1992-2007 [ASH Annual Meeting Abstracts]. Blood. 2010; 116: 872.
11. Au WY, Lie AK, Chim CS, Liang R, Ma SK, Chan CH, et al. Arsenic trioxide in comparison with chemotherapy and bone marrow transplantation for the treatment of relapsed acute promyelocytic leukaemia. Ann Oncol. 2003; 14: 752-757. (Pubitemid 36621776)
12. de Botton S, Fawaz A, Chevret S, Dombret H, Thomas X, Sanz M, et al. Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: A retrospective analysis of the European Acute Promyelocytic Leukemia Group. J Clin Oncol. 2005; 23: 120-126. (Pubitemid 41702630)
13. Dvorak CC, Agarwal R, Dahl GV, Gregory JJ, Feusner JH. Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia. Biol Blood Marrow Transplant. 2008; 14: 824-830. (Pubitemid 351773159)
14. Linker CA, Owzar K, Powell B, Hurd D, Damon LE, Archer LE, et al. Auto-SCT for AML in second remission: CALGB Study 9620. Bone Marrow Transplant. 2009; 44: 353-359.